{"category":{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-05T04:09:36.463Z","updated_at":"2026-09-05T04:09:36.463Z","example":false,"profile_url":"/categories/gene-therapy","is_stub":true,"member_count":14,"member_counts":{"product":14}},"members":[{"listing_type":"product","name":"Hydropore","slug":"hydropore","tagline":"A non-viral intracellular delivery system using microfluidic vortex shedding to deliver nucleic acids and gene-editing complexes into T cells for cell therapy…","description":"Hydropore by Indee Labs utilizes microfluidic vortex shedding (µVS) technology to rapidly deliver small molecules, nucleic acids, proteins, and gene-editing complexes into immune cells in seconds, yielding millions to billions of high-quality cells with negligible impact on viability and function. The system bypasses the limitations of viral transduction and traditional electroporation, enabling acceleration from discovery through manufacturing. Hydropore is developed in an ISO 13485-compliant, regulatory-ready manner using medical-grade materials and is currently available for research use only.\n\nHydropore is a product of Indee Labs.","url":"https://www.indeelabs.com/","is_stealth":false,"normalized_domain":"indeelabs.com","normalized_url_key":"indeelabs.com","parent_slug":"indee-labs","parent":{"slug":"indee-labs","name":"Indee Labs","listing_type":"company","profile_url":"/companies/indee-labs"},"type_data":{"product_kind":"hardware","pricing_model":"other","free_tier":false,"open_source":false,"use_cases":["T cell immunotherapy manufacturing","Gene editing delivery to immune cells","High-throughput cell therapy screening","Non-viral transfection"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.indeelabs.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.indeelabs.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Cell Therapy","Medical Devices","Drug Discovery","Healthcare","Drug Discovery and Delivery","Gene Therapy","Microfluidics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:40:08.296Z","added_via":"web","geo":{"keywords":["Hydropore","Indee Labs","Biotech","Cell Therapy","Medical Devices","Drug Discovery","Healthcare","Drug Discovery and Delivery","Gene Therapy","Microfluidics"],"canonical_facts":["Product of Indee Labs"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:40:08.296Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/categories/medical-devices"},{"kind":"product_category","slug":"microfluidics","name":"Microfluidics","note":null,"profile_url":"/categories/microfluidics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:40:08.296Z","updated_at":"2026-09-05T07:40:08.296Z"}},{"listing_type":"product","name":"VectorSelect","slug":"vectorselect","tagline":"Massively parallelized cell line engineering platform that accelerates manufacturing of gene and cell therapies.","description":"VectorSelect is 64x Bio's core platform that combines massively parallel screens with computational insights to engineer high-yield cell lines and production technologies for advanced therapeutics. The platform powers three product suites: AAV Apex Suite for high-yield AAV gene therapy production, LV Apex Suite for lentiviral vector production supporting CAR-T programs, and Next Apex Suite for biologics including antibodies. Partners license high-performing cell lines through these Apex Suites or use VectorSelect for flexible cell line optimization.\n\nVectorSelect is a product of 64x Bio.","url":"https://64xbio.com/","is_stealth":false,"normalized_domain":"64xbio.com","normalized_url_key":"64xbio.com","parent_slug":"64x-bio","parent":{"slug":"64x-bio","name":"64x Bio","listing_type":"company","profile_url":"/companies/64x-bio"},"type_data":{"product_kind":"service","pricing_model":"enterprise","free_tier":false,"open_source":false,"use_cases":["AAV gene therapy manufacturing","CAR-T lentiviral vector production","biologics manufacturing","cell line engineering","advanced therapy scale-up"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://64xbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://64xbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Gene Therapy","Machine Learning","Biotech"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:29:39.234Z","added_via":"web","geo":{"keywords":["VectorSelect","64x Bio","Healthcare","Industrial Bio","Gene Therapy","Machine Learning","Biotech"],"canonical_facts":["Product of 64x Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:29:39.234Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/categories/industrial-bio"},{"kind":"product_category","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/categories/machine-learning"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:29:39.234Z","updated_at":"2026-09-05T07:29:39.234Z"}},{"listing_type":"product","name":"Sixfold Bio","slug":"sixfold-bio","tagline":"AI-enhanced RNA delivery platform using evolution-inspired approaches to advance siRNA and mRNA therapeutics.","description":"Sixfold Bio is developing a patented drug delivery system for RNA therapies, including siRNAs for gene silencing and mRNAs for gene expression. The company combines evolutionary biology approaches with AI to optimize delivery solutions, targeting commercialization of its RNA delivery platform for pharmaceutical partners. The company's Mergo platform is its featured delivery technology.\n\nSixfold Bio is a product of Sixfold Bioscience.","url":"https://www.sixfold.bio/","is_stealth":false,"normalized_domain":"sixfold.bio","normalized_url_key":"sixfold.bio","parent_slug":"sixfold-bioscience","parent":{"slug":"sixfold-bioscience","name":"Sixfold Bioscience","listing_type":"company","profile_url":"/companies/sixfold-bioscience"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["siRNA gene silencing delivery","mRNA therapy delivery","RNA drug delivery platform licensing"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.sixfold.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.sixfold.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Delivery","Gene Therapy","Nanomedicine","Biotech","Drug Discovery and Delivery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:23:54.302Z","added_via":"web","geo":{"keywords":["Sixfold Bio","Sixfold Bioscience","Healthcare","Drug Delivery","Gene Therapy","Nanomedicine","Biotech","Drug Discovery and Delivery"],"canonical_facts":["Product of Sixfold Bioscience"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:23:54.302Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/categories/drug-delivery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/categories/nanomedicine"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:23:54.302Z","updated_at":"2026-09-05T07:23:54.302Z"}},{"listing_type":"product","name":"Rejuvenation Technologies","slug":"rejuvenation-technologies","tagline":"mRNA-based telomere extension therapy using proprietary lipid nanoparticle delivery to reverse cellular aging in specific tissues.","description":"Rejuvenation Technologies is developing a clinical-stage therapeutic platform using modified mRNA delivered via proprietary lipid nanoparticles to temporarily activate telomerase and extend telomeres in targeted human cells. The company holds over 40 granted patents and has received more than $8M in grant funding since 2023. Target disease areas include pulmonary fibrosis, liver disease, and bone marrow failure. Preclinical studies have demonstrated reversal of 5+ years of telomere shortening in one day.\n\nRejuvenation Technologies is a product of Rejuvenation Technologies Inc..","url":"https://rejuvenationtech.com/","is_stealth":false,"normalized_domain":"rejuvenationtech.com","normalized_url_key":"rejuvenationtech.com","parent_slug":"rejuvenation-technologies-inc","parent":{"slug":"rejuvenation-technologies-inc","name":"Rejuvenation Technologies Inc.","listing_type":"company","profile_url":"/companies/rejuvenation-technologies-inc"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["pulmonary fibrosis treatment","liver disease treatment","bone marrow failure treatment","cellular age reversal"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Anti-Aging","Gene Therapy","Nanomedicine"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:23:46.414Z","added_via":"web","geo":{"keywords":["Rejuvenation Technologies","Rejuvenation Technologies Inc.","Healthcare","Therapeutics","Anti-Aging","Gene Therapy","Nanomedicine"],"canonical_facts":["Product of Rejuvenation Technologies Inc."]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:23:46.414Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"anti-aging","name":"Anti-Aging","note":null,"profile_url":"/categories/anti-aging"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/categories/nanomedicine"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:23:46.414Z","updated_at":"2026-09-05T07:23:46.414Z"}},{"listing_type":"product","name":"Nephrogen","slug":"nephrogen-product","tagline":"AI and high-throughput in vivo screening platform (NeFIND) that engineers AAV delivery vehicles 10–100x more efficient for kidney and pancreatic gene therapy.","description":"Nephrogen is a Stanford biotech spinout developing curative genetic medicines for kidney and pancreatic diseases using their NeFIND platform, which combines AI and high-throughput in vivo screening to design and validate novel AAV delivery vehicles with tissue-specific tropism. The identified AAV vectors are 10–100x more efficient, cheaper, and less immunogenic than existing options, enabling gene therapy for diseases affecting 1 in 7 Americans that currently have no approved gene-based treatments. The company is co-founded by a Stanford computational biologist and a Stanford nephrologist.\n\nNephrogen is a product of Nephrogen.","url":"https://www.nephrogenbiotech.com/","is_stealth":false,"normalized_domain":"nephrogenbiotech.com","normalized_url_key":"nephrogenbiotech.com","parent_slug":"nephrogen","parent":{"slug":"nephrogen","name":"Nephrogen","listing_type":"company","profile_url":"/companies/nephrogen"},"type_data":{"product_kind":"other","pricing_model":"enterprise","free_tier":false,"open_source":false,"use_cases":["Gene therapy delivery","Kidney disease treatment","Pancreatic disease treatment","AAV vector design","Pharma licensing"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Gene Therapy","Healthcare","AI","Drug Discovery","Therapeutics","CRISPR"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:11:29.593Z","added_via":"web","geo":{"keywords":["Nephrogen","Nephrogen","Biotech","Gene Therapy","Healthcare","AI","Drug Discovery","Therapeutics","CRISPR"],"canonical_facts":["Product of Nephrogen"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:11:29.593Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:11:29.593Z","updated_at":"2026-09-05T07:11:29.593Z"}},{"listing_type":"product","name":"Nuntius Therapeutics","slug":"nuntius-therapeutics-product","tagline":"Biotech platform developing programmable nanocarrier delivery systems and engineered mRNA therapeutics targeting cancer, lung, and neurodegenerative diseases.","description":"Nuntius Therapeutics is a biotech company building cell-specific genetic medicine technology through three capability pillars: programmable non-immunogenic nanocarriers that can target tissues beyond the liver; ML models that predict carrier quality and performance across millions of candidates; and engineered mRNA with superior protein expression compared to clinically used mRNA. The company is advancing a drug pipeline targeting cancer, lung diseases, and neurodegenerative diseases, with operations in Delaware, USA and London, UK.\n\nNuntius Therapeutics is a product of Nuntius Therapeutics.","url":"https://nuntiustx.com/","is_stealth":false,"normalized_domain":"nuntiustx.com","normalized_url_key":"nuntiustx.com","parent_slug":"nuntius-therapeutics","parent":{"slug":"nuntius-therapeutics","name":"Nuntius Therapeutics","listing_type":"company","profile_url":"/companies/nuntius-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Cancer therapy development","Lung disease treatment","Neurodegenerative disease treatment","mRNA drug delivery"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://nuntiustx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nuntiustx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Gene Therapy","Drug Discovery","Healthcare","Therapeutics","Nanomedicine"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:38:29.336Z","added_via":"web","geo":{"keywords":["Nuntius Therapeutics","Nuntius Therapeutics","Biotech","Gene Therapy","Drug Discovery","Healthcare","Therapeutics","Nanomedicine"],"canonical_facts":["Product of Nuntius Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:38:29.336Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/categories/nanomedicine"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:38:29.336Z","updated_at":"2026-09-05T06:38:29.336Z"}},{"listing_type":"product","name":"WhiteLab Genomics","slug":"whitelab-genomics-platform","tagline":"AI platform that accelerates cell and gene therapy drug discovery through rational design of molecular constructs and vectors.","description":"WhiteLab Genomics uses a proprietary AI-led framework combining advanced algorithms, curated databases, and computational biology to optimize therapeutic candidates for genomic medicine. The platform covers target receptor identification, viral vector design across AAV, lentivirus, and nanoparticle modalities, non-viral vector design, payload design, and bioproduction optimization. It is designed to accelerate and de-risk discovery for cell therapy, RNA therapy, and DNA therapy programs for biotech and pharma collaborators. Founded in 2019 and backed by Y Combinator.\n\nWhiteLab Genomics is a product of WhiteLab Genomics.","url":"https://whitelabgx.com/","is_stealth":false,"normalized_domain":"whitelabgx.com","normalized_url_key":"whitelabgx.com","parent_slug":"whitelab-genomics","parent":{"slug":"whitelab-genomics","name":"WhiteLab Genomics","listing_type":"company","profile_url":"/companies/whitelab-genomics"},"type_data":{"product_kind":"saas","pricing_model":"enterprise","platforms":["web"],"free_tier":false,"open_source":false,"launched_year":2019,"use_cases":["Gene therapy design","Cell therapy optimization","RNA therapy development","Viral vector design","Bioproduction optimization"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://whitelabgx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://whitelabgx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","AI","Drug Discovery and Delivery","Genomics","Artificial Intelligence","Gene Therapy","Cell Therapy"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:28:57.938Z","added_via":"web","geo":{"keywords":["WhiteLab Genomics","WhiteLab Genomics","Healthcare","AI","Drug Discovery and Delivery","Genomics","Artificial Intelligence","Gene Therapy","Cell Therapy"],"canonical_facts":["Product of WhiteLab Genomics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:28:57.938Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/categories/artificial-intelligence"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:28:57.938Z","updated_at":"2026-09-05T06:28:57.938Z"}},{"listing_type":"product","name":"DynaChip X1","slug":"dynachip-x1","tagline":"Next-generation microfluidic mass spectrometry sample preparation device that simplifies and accelerates bioanalytical workflows.","description":"The DynaChip X1 by Andson Biotech is a mass spectrometry sample preparation platform that combines microfluidic design with analytical performance. It is designed to remove technical barriers for pharmaceutical companies measuring difficult-to-detect chemicals during drug development and quality control for cell therapies and biologics. The device aims to simplify and accelerate complex MS workflows that drug companies perform thousands of times per day.\n\nDynaChip X1 is a product of Andson Biotech.","url":"http://www.andsonbiotech.com/","is_stealth":false,"normalized_domain":"andsonbiotech.com","normalized_url_key":"andsonbiotech.com","parent_slug":"andson-biotech","parent":{"slug":"andson-biotech","name":"Andson Biotech","listing_type":"company","profile_url":"/companies/andson-biotech"},"type_data":{"product_kind":"hardware","open_source":false,"use_cases":["Drug development analytical testing","Biologic quality control","Cell therapy characterization","Mass spectrometry workflow acceleration"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"http://www.andsonbiotech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"http://www.andsonbiotech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Hardware","Drug Discovery","Gene Therapy","Hard Tech","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:59:51.879Z","added_via":"web","geo":{"keywords":["DynaChip X1","Andson Biotech","Biotech","Healthcare","Hardware","Drug Discovery","Gene Therapy","Hard Tech","Therapeutics"],"canonical_facts":["Product of Andson Biotech"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:59:51.879Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/categories/hard-tech"},{"kind":"product_category","slug":"hardware","name":"Hardware","note":null,"profile_url":"/categories/hardware"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:59:51.879Z","updated_at":"2026-09-05T05:59:51.879Z"}},{"listing_type":"product","name":"Nanograb","slug":"nanograb-product","tagline":"AI-driven platform designing multivalent nanoparticles with peptide binders for cell-selective non-viral gene therapy delivery.","description":"Nanograb is a computational drug discovery company that uses generative AI to design nanoparticles that deliver genetic medicines to specific cells and tissues without viral vectors. Its platform combines small peptide binders attached to nanoparticles to create targeted non-viral gene therapy delivery systems, aiming to enable disease treatment without systemic side effects and at scale. The approach is designed to avoid the limitations and manufacturing challenges of traditional viral delivery vectors.\n\nNanograb is a product of Nanograb.","url":"https://nanograb.com/","is_stealth":false,"normalized_domain":"nanograb.com","normalized_url_key":"nanograb.com","parent_slug":"nanograb","parent":{"slug":"nanograb","name":"Nanograb","listing_type":"company","profile_url":"/companies/nanograb"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["non-viral gene therapy delivery","targeted cell delivery","genetic medicine development"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://nanograb.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://nanograb.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","AI","Drug Delivery","Gene Therapy","Drug Discovery and Delivery","AI-powered Drug Discovery","Nanomedicine"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:50:03.793Z","added_via":"web","geo":{"keywords":["Nanograb","Nanograb","Biotech","Healthcare","AI","Drug Delivery","Gene Therapy","Drug Discovery and Delivery","AI-powered Drug Discovery","Nanomedicine"],"canonical_facts":["Product of Nanograb"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:50:03.793Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/categories/drug-delivery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/categories/nanomedicine"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:50:03.793Z","updated_at":"2026-09-05T05:50:03.793Z"}},{"listing_type":"product","name":"Modulari-T","slug":"modulari-t-product","tagline":"Biotech platform developing next-generation modular immune receptors and in vivo gene delivery vehicles to overcome CAR-T therapy limitations.","description":"Modulari-T develops two core technologies for cell and gene therapy: MARC (Modular Actuation Receptor Complex), a next-generation immune receptor with separate targeting and signaling, on/off control, bispecific options, and reduced exhaustion validated across five cell types; and MoVe (Modular Vector), the first rationally designed in vivo delivery vehicle for gene therapy that avoids liver toxicity and precisely targets immune or non-immune cells. The platform is designed to expand cell therapies beyond hematologic malignancies to solid tumors, autoimmune diseases, and other conditions.\n\nModulari-T is a product of Modulari-T.","url":"https://modularit.bio/","is_stealth":false,"normalized_domain":"modularit.bio","normalized_url_key":"modularit.bio","parent_slug":"modulari-t","parent":{"slug":"modulari-t","name":"Modulari-T","listing_type":"company","profile_url":"/companies/modulari-t"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["cancer cell therapy","gene delivery","autoimmune disease treatment","next-generation CAR-T development"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Cell Therapy","Gene Therapy","Synthetic Biology","Therapeutics","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:49:53.383Z","added_via":"web","geo":{"keywords":["Modulari-T","Modulari-T","Biotech","Healthcare","Cell Therapy","Gene Therapy","Synthetic Biology","Therapeutics","Oncology"],"canonical_facts":["Product of Modulari-T"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:49:53.383Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:49:53.383Z","updated_at":"2026-09-05T05:49:53.383Z"}},{"listing_type":"product","name":"APEXm","slug":"apexm","tagline":"Proprietary mRNA platform that achieves dramatically higher and more durable protein expression for next-generation therapeutics.","description":"APEXm (Amplified and Prolonged Expression mRNA) is ParcelBio's core platform that uses proprietary RNA domains to recruit the cell's native stabilizing machinery, producing significantly higher and longer-lasting protein expression than conventional mRNA. The modular platform can encode any protein in any target cell type and is being deployed for in vivo CAR-T in autoimmune diseases, oncology, and therapeutic protein delivery. ParcelBio is backed by Breyer Capital, Y Combinator, and General Catalyst.\n\nAPEXm is a product of ParcelBio.","url":"https://parcelbio.com/","is_stealth":false,"normalized_domain":"parcelbio.com","normalized_url_key":"parcelbio.com","parent_slug":"parcelbio","parent":{"slug":"parcelbio","name":"ParcelBio","listing_type":"company","profile_url":"/companies/parcelbio"},"type_data":{"product_kind":"other","free_tier":false,"open_source":false,"use_cases":["In vivo CAR-T for autoimmune disease","Oncology therapeutics","Therapeutic protein delivery via mRNA"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://parcelbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://parcelbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Drug Discovery","Therapeutics","Gene Therapy","Synthetic Biology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:30:46.862Z","added_via":"web","geo":{"keywords":["APEXm","ParcelBio","Biotech","Healthcare","Drug Discovery","Therapeutics","Gene Therapy","Synthetic Biology"],"canonical_facts":["Product of ParcelBio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:30:46.862Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:30:46.862Z","updated_at":"2026-09-05T05:30:46.862Z"}},{"listing_type":"product","name":"Kopra Bio","slug":"kopra-bio-product","tagline":"Cancer immunotherapy that genetically engineers viruses to turn cancer cells into biofactories for their own destruction.","description":"Kopra Bio develops genetically engineered virus-based cancer immunotherapies that reprogram tumor cells to produce agents of their own destruction. The company's lead program targets glioblastoma, the most aggressive form of brain cancer, using technology developed at UCSF. In preclinical models, Kopra Bio's treatment improved survival from 0% with the current FDA-approved standard of care to 90%. The company is pursuing a next-generation immunotherapy with a market opportunity analogous to Keytruda, the $25B/year cancer drug.\n\nKopra Bio is a product of Kopra Bio.","url":"https://www.kopra.bio/","is_stealth":false,"normalized_domain":"kopra.bio","normalized_url_key":"kopra.bio","parent_slug":"kopra-bio","parent":{"slug":"kopra-bio","name":"Kopra Bio","listing_type":"company","profile_url":"/companies/kopra-bio"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["glioblastoma treatment","cancer immunotherapy"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Oncology","Gene Therapy","Synthetic Biology","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:24:12.987Z","added_via":"web","geo":{"keywords":["Kopra Bio","Kopra Bio","Healthcare","Biotech","Oncology","Gene Therapy","Synthetic Biology","Therapeutics"],"canonical_facts":["Product of Kopra Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:24:12.987Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:24:12.987Z","updated_at":"2026-09-05T05:24:12.987Z"}},{"listing_type":"product","name":"Uncommon Therapeutics","slug":"uncommon-therapeutics-product","tagline":"Developing polytherapy drug treatments for rare genetic diseases, starting with Rett Syndrome.","description":"Uncommon Therapeutics develops drugs targeting the underlying cause of rare diseases using latest biotechnologies including gene therapy and CRISPR. Their first indication is Rett Syndrome, a neurodevelopmental monogenetic disorder affecting 1 in 10,000 girls. The company's polytherapy approach has unlocked multiple candidate therapeutics that together could deliver a cure.\n\nUncommon Therapeutics is a product of Uncommon Therapeutics.","url":"https://www.uncommontherapeutics.com/","is_stealth":false,"normalized_domain":"uncommontherapeutics.com","normalized_url_key":"uncommontherapeutics.com","parent_slug":"uncommon-therapeutics","parent":{"slug":"uncommon-therapeutics","name":"Uncommon Therapeutics","listing_type":"company","profile_url":"/companies/uncommon-therapeutics"},"type_data":{"product_kind":"other","use_cases":["Rett Syndrome treatment","rare disease therapy","polytherapy drug development"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotechnology","Healthcare","Therapeutics","Gene Therapy","CRISPR"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:15:42.749Z","added_via":"web","geo":{"keywords":["Uncommon Therapeutics","Uncommon Therapeutics","Biotechnology","Healthcare","Therapeutics","Gene Therapy","CRISPR"],"canonical_facts":["Product of Uncommon Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:15:42.749Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:15:42.749Z","updated_at":"2026-09-05T05:15:42.749Z"}},{"listing_type":"product","name":"FinalDose","slug":"finaldose-product","tagline":"Programmable DNA drug platform designed to search and destroy cancer cells upon DNA recognition, targeting previously undruggable mutations.","description":"FinalDose is developing a programmable drug molecule that can be configured with any diseased genetic code to search and destroy cells upon DNA recognition. The company claims the platform can unlock approximately 80% of previously undruggable cancer targets and is starting with all cancers. The site links to a whitepaper describing the complete architecture for cancer therapy.\n\nFinalDose is a product of FinalDose.","url":"https://www.finaldose.ai/","is_stealth":false,"normalized_domain":"finaldose.ai","normalized_url_key":"finaldose.ai","parent_slug":"finaldose","parent":{"slug":"finaldose","name":"FinalDose","listing_type":"company","profile_url":"/companies/finaldose"},"type_data":{"product_kind":"other","open_source":false,"docs_url":"https://www.finaldose.ai/whitepaper/","use_cases":["cancer therapy","undruggable target engagement","DNA-targeted cancer treatment"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.finaldose.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"docs","url":"https://www.finaldose.ai/whitepaper/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.finaldose.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":{"kind":"docs","url":"https://www.finaldose.ai/whitepaper/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}},"founders":[],"media":null,"categories":["Healthcare","Biotech","Therapeutics","Gene Therapy","Oncology","Artificial Intelligence","Genetic Engineering"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T04:09:36.463Z","added_via":"web","geo":{"keywords":["FinalDose","FinalDose","Healthcare","Biotech","Therapeutics","Gene Therapy","Oncology","Artificial Intelligence","Genetic Engineering"],"canonical_facts":["Product of FinalDose"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T04:09:36.463Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/categories/artificial-intelligence"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"genetic-engineering","name":"Genetic Engineering","note":null,"profile_url":"/categories/genetic-engineering"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T04:09:36.463Z","updated_at":"2026-09-05T04:09:36.463Z"}}],"total":14,"limit":50,"offset":0}